Gueremy C - Search Results

1

1-[4-(2-ter-butyl-quinolyl)]-3-(4-piperidyl)propanol (PK 10139): a new potent and long-acting antiarrhythmic agent.

Mestre M, Bouetard G, Le Fur G, Renault C, Gueremy C, Uzan A. Mestre M, et al. Among authors: gueremy c. J Pharmacol Exp Ther. 1983 Apr;225(1):158-63. J Pharmacol Exp Ther. 1983. PMID: 6834268

2

PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog.

Mestre M, Bouetard G, Uzan A, Gueremy C, Renault C, Dubroeucq MC, Le Fur G. Mestre M, et al. Among authors: gueremy c. Eur J Pharmacol. 1985 Jun 7;112(2):257-60. doi: 10.1016/0014-2999(85)90505-9. Eur J Pharmacol. 1985. PMID: 2992998

3

Characterization of solubilized "peripheral type" benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative.

Benavides J, Menager J, Burgevin MC, Ferris O, Uzan A, Gueremy C, Renault C, Le Fur G. Benavides J, et al. Among authors: gueremy c. Biochem Pharmacol. 1985 Jan 15;34(2):167-70. doi: 10.1016/0006-2952(85)90119-4. Biochem Pharmacol. 1985. PMID: 2981532

4

Modulation of voltage-operated, but not receptor-operated, calcium channels in the rabbit aorta by PK 11195, an antagonist of peripheral-type benzodiazepine receptors.

Mestre M, Belin C, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G. Mestre M, et al. Among authors: gueremy c. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):729-34. J Cardiovasc Pharmacol. 1986. PMID: 2427811

5

Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative.

Dubroeucq MC, Bénavidès J, Doble A, Guilloux F, Allam D, Vaucher N, Bertrand P, Guérémy C, Renault C, Uzan A, et al. Dubroeucq MC, et al. Among authors: gueremy c. Eur J Pharmacol. 1986 Sep 9;128(3):269-72. doi: 10.1016/0014-2999(86)90776-4. Eur J Pharmacol. 1986. PMID: 3024996

6

Characterization of peripheral type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195. Studies in hypertensive patients.

Benavides J, Quarteronet D, Plouin PF, Imbault F, Phan T, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G. Benavides J, et al. Among authors: gueremy c. Biochem Pharmacol. 1984 Aug 1;33(15):2467-72. doi: 10.1016/0006-2952(84)90719-6. Biochem Pharmacol. 1984. PMID: 6087829

7

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies.

Le Fur G, Guilloux F, Rufat P, Benavides J, Uzan A, Renault C, Dubroeucq MC, Guérémy C. Le Fur G, et al. Among authors: gueremy c. Life Sci. 1983 Apr 18;32(16):1849-56. doi: 10.1016/0024-3205(83)90063-2. Life Sci. 1983. PMID: 6300589

8

In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.

Benavides J, Guilloux F, Rufat P, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G. Benavides J, et al. Among authors: gueremy c. Eur J Pharmacol. 1984 Mar 16;99(1):1-7. doi: 10.1016/0014-2999(84)90425-4. Eur J Pharmacol. 1984. PMID: 6723786

9

Photoaffinity labeling of peripheral-type benzodiazepine-binding sites.

Doble A, Ferris O, Burgevin MC, Menager J, Uzan A, Dubroeucq MC, Renault C, Gueremy C, Le Fur G. Doble A, et al. Among authors: gueremy c. Mol Pharmacol. 1987 Jan;31(1):42-9. Mol Pharmacol. 1987. PMID: 3027525

10

The 5-hydroxytryptamine-releasing properties of two epimer quinoline derivatives.

Le Fur G, Imbault F, Mitrani N, Marquis F, Renault C, Dubroeucq MC, Gueremy C, Uzan A. Le Fur G, et al. Among authors: gueremy c. Neuropharmacology. 1984 Feb;23(2A):169-73. Neuropharmacology. 1984. PMID: 6717757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters